T cells are required for the CMV-induced anti-leukemic effect in patients with acute myeloid leukemia patients after transplant

被引：0
|
作者：
Elmaagacli, A. H. [1 ,2 ]
Koldehoff, M. [1 ]
Sonius, M. [1 ]
Steckel, N. K. [1 ]
Trenschel, R. [1 ]
Ditschkowski, M. [1 ]
Gromke, T. [1 ]
Ross, R. S. [2 ]
Ottinger, H. [1 ]
Beelen, D. [1 ]
机构：
[1] Uniklin Essen, KMT, Essen, Germany
[2] Uniklin Essen, Inst Virol, Essen, Germany
来源：
ONKOLOGIE | 2012年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：173 / 173
页数：1
相关论文
共 50 条
  • [41] CLONAL HETEROGENEITY IN LEUKEMIC STEM CELLS FROM PATIENTS WITH ACUTE MYELOID LEUKEMIA
    Manta, L.
    Saeed, B.
    Beiro, L. Poisa
    Pyl, P.
    Stiehl, T.
    Barth-Miesala, K.
    Eckstein, V.
    Huber, W.
    Ho, A. D.
    Lutz, C.
    HAEMATOLOGICA, 2017, 102 : 51 - 51
  • [42] The progenitor cell inhibition assay to measure the anti-leukemic reactivity of T cell clones against acute and chronic myeloid leukemia
    van der Hoorn, MAWG
    van Luxemburg-Heijs, SAP
    van Bergen, CAM
    Bongaerts, R
    Willemze, R
    Falkenburg, JHF
    METHODS, 2003, 31 (02) : 113 - 119
  • [43] The Hedgehog pathway mediator GLI confers a negative prognosis on patients with acute myeloid leukemia and GLI inhibition results in anti-leukemic effects in vitro
    Wellbrock, J.
    Latuske, E.
    Koehler, J.
    Wagner, K.
    Stamm, H.
    Vettorazzi, E.
    Vohwinkel, G.
    Klokow, M.
    Kuehling-Thees, R.
    Loges, S.
    Thol, F.
    Schubert, C.
    Amling, M.
    Juecker, M.
    Bokemeyer, C.
    Heuser, M.
    Krauter, J.
    Fiedler, W.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 224 - 224
  • [44] Anti-leukemic effects of all-trans retinoic acid in combination with Daratumumab in acute myeloid leukemia
    Buteyn, Nathaniel J.
    Fatehchand, Kavin
    Santhanam, Ramasamy
    Fang, Huiqing
    Dettorre, Gino M.
    Gautam, Shalini
    Harrington, Bonnie K.
    Henderson, Sally E.
    Merchand-Reyes, Giovanna
    Mo, Xiaokui
    Benson, Don M.
    Carson, William E., III
    Vasu, Sumithira
    Byrd, John C.
    Butchar, Jonathan P.
    Tridandapani, Susheela
    INTERNATIONAL IMMUNOLOGY, 2018, 30 (08) : 375 - 383
  • [45] In vitro and in vivo anti-leukemic activity of the peptidase-potentiated alkylator melflufen in acute myeloid leukemia
    Strese, Sara
    Hassan, Saadia Bashir
    Velander, Ebba
    Haglund, Caroline
    Hoglund, Martin
    Larsson, Rolf
    Gullbo, Joachim
    ONCOTARGET, 2017, 8 (04) : 6341 - 6352
  • [46] Anti-leukemic activity of Cyperus rotundus L.on human acute myeloid leukemia HL-60 cells in vitro
    Agustini, Sulistyo Mulyo
    Widjajanto, Edi
    Rifa'i, Muhaimin
    Haryana, Sofia Mubarika
    Nurdiana
    Lyrawati, Diana
    Sukorini, Usi
    Lestari, Noviana Dwi
    JOURNAL OF PHARMACY & PHARMACOGNOSY RESEARCH, 2023, 11 (01): : 191 - 197
  • [47] Combined anti-leukemic effect of gilteritinib and GSK-J4 in FLT3-ITD+ acute myeloid leukemia
    Zhou, Qi
    Guan, Yongyu
    Zhao, Pingping
    Chu, Huiyuan
    Xi, Yaming
    TRANSLATIONAL ONCOLOGY, 2025, 52
  • [48] Anti-leukemic mechanisms of pegylated arginase I in acute lymphoblastic T-cell leukemia
    Morrow, K.
    Hernandez, C. P.
    Raber, P.
    Del Valle, L.
    Wilk, A. M.
    Majumdar, S.
    Wyczechowska, D.
    Reiss, K.
    Rodriguez, P. C.
    LEUKEMIA, 2013, 27 (03) : 569 - 577
  • [49] Potential for therapy with leukemic dendritic cells derived from patients with acute myeloid leukemia
    Mohty, M
    Isnardon, D
    Blaise, D
    Brière, F
    Gastaut, JA
    Olive, D
    Gaugler, B
    BONE MARROW TRANSPLANTATION, 2002, 29 : S76 - S76
  • [50] Identification of precursors of leukemic dendritic cells differentiated from patients with acute myeloid leukemia
    Mohty, M
    Isnardon, D
    Blaise, D
    Mozziconacci, MJ
    Lafage-Pochitaloff, M
    Brière, F
    Gastaut, JA
    Olive, D
    Gaugler, B
    LEUKEMIA, 2002, 16 (11) : 2267 - 2274
12345